Joseph Douglas Lyon - 01 Mar 2024 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Accounting Officer
Signature
/s/ Joseph Douglas Lyon
Issuer symbol
CORT
Transactions as of
01 Mar 2024
Net transactions value
+$794
Form type
4
Filing time
05 Mar 2024, 21:19:45 UTC
Previous filing
21 Feb 2024
Next filing
03 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Tax liability $11,404 -474 -7% $24.06 6,300 01 Mar 2024 Direct F1, F2
transaction CORT Common Stock Award $12,198 +507 +8% $24.06 6,807 01 Mar 2024 Direct F2, F3, F4
transaction CORT Common Stock Award $0 +507 +7.4% $0.000000 7,314 01 Mar 2024 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
F2 Includes 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
F3 The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on March 1, 2024.
F4 In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.
F5 Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.